Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L J Kelly

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Chemotherapy|September 19, 2001
Comparative activity of cefditoren and other oral beta-lactams against nonpneumococcal streptococciC Thornsberry, J A Karlowsky, L J Kelly, et al.
Antimicrobial Agents and Chemotherapy|March 21, 2001
Need for annual surveillance of antimicrobial resistance in Streptococcus pneumoniae in the United States: 2-year longitudinal analysisD F Sahm, J A Karlowsky, L J Kelly, et al.
Antimicrobial Agents and Chemotherapy|December 20, 2000
Evaluation of current activities of fluoroquinolones against gram-negative bacilli using centralized in vitro testing and electronic surveillanceD F Sahm, I A Critchley, L J Kelly, et al.
Growth Factors (Chur, Switzerland)|January 1, 1990
Disulfide bonds are neither required, present, nor compatible with full activity of human recombinant acidic fibroblast growth factorD L Linemeyer, J G Menke, L J Kelly, et al.
Molecular Pharmacology|August 23, 2000
Evidence for peroxisome proliferator-activated receptor (PPAR)alpha-independent peroxisome proliferation: effects of PPARgamma/delta-specific agonists in PPARalpha-null miceJ G DeLuca, T W Doebber, L J Kelly, et al.
Endocrinology|December 1, 1998
Peroxisome proliferator-activated receptors gamma and alpha mediate in vivo regulation of uncoupling protein (UCP-1, UCP-2, UCP-3) gene expressionL J Kelly, P P Vicario, G M Thompson, et al.
The Journal of Clinical Investigation|June 17, 1998
A selective human beta3 adrenergic receptor agonist increases metabolic rate in rhesus monkeysM H Fisher, A M Amend, T J Bach, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Chemotherapy|September 19, 2001
Comparative activity of cefditoren and other oral beta-lactams against nonpneumococcal streptococciC Thornsberry, J A Karlowsky, L J Kelly, et al.
Antimicrobial Agents and Chemotherapy|March 21, 2001
Need for annual surveillance of antimicrobial resistance in Streptococcus pneumoniae in the United States: 2-year longitudinal analysisD F Sahm, J A Karlowsky, L J Kelly, et al.
Antimicrobial Agents and Chemotherapy|December 20, 2000
Evaluation of current activities of fluoroquinolones against gram-negative bacilli using centralized in vitro testing and electronic surveillanceD F Sahm, I A Critchley, L J Kelly, et al.
Growth Factors (Chur, Switzerland)|January 1, 1990
Disulfide bonds are neither required, present, nor compatible with full activity of human recombinant acidic fibroblast growth factorD L Linemeyer, J G Menke, L J Kelly, et al.
Molecular Pharmacology|August 23, 2000
Evidence for peroxisome proliferator-activated receptor (PPAR)alpha-independent peroxisome proliferation: effects of PPARgamma/delta-specific agonists in PPARalpha-null miceJ G DeLuca, T W Doebber, L J Kelly, et al.
Endocrinology|December 1, 1998
Peroxisome proliferator-activated receptors gamma and alpha mediate in vivo regulation of uncoupling protein (UCP-1, UCP-2, UCP-3) gene expressionL J Kelly, P P Vicario, G M Thompson, et al.
The Journal of Clinical Investigation|June 17, 1998
A selective human beta3 adrenergic receptor agonist increases metabolic rate in rhesus monkeysM H Fisher, A M Amend, T J Bach, et al.
Pageof 4